Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-24-046973
Filing Date
2024-11-14
Accepted
2024-11-14 17:05:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A ef20038680_sc13ga.htm SC 13G/A 49744
  Complete submission text file 0001140361-24-046973.txt   51461
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Subject) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88225 | Film No.: 241464096
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 399 PARK AVENUE NEW YORK NY 10022
Business Address 399 PARK AVENUE NEW YORK NY 10022 212-287-6787
Blue Owl Capital Holdings LP (Filed by) CIK: 0001858703 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A